Etiology, pathogenesis, hematologic indices, and peripheral blood characteristics of acquired hemolytic anemia
Hematologic indices used to assess hemolytic anemia
Acquired hemolytic anemia is a condition characterized by premature destruction of red blood cells. It can result from immune or non-immune mechanisms and is diagnosed through hematologic indices and blood smear analysis.
Etiology, Pathogenesis, Hematologic Indices, and Peripheral Blood Characteristics of Acquired Hemolytic Anemia
Acquired hemolytic anemia is a condition where premature destruction of red blood cells (RBCs) leads to anemia. It can be caused by various factors, including autoimmune disorders, infections, medications, and mechanical damage.
Etiology
The causes of acquired hemolytic anemia can be broadly classified into immune and non-immune mechanisms:
- Immune-mediated hemolysis: Autoimmune hemolytic anemia (AIHA), drug-induced hemolysis, alloimmune hemolysis.
- Non-immune hemolysis: Microangiopathic hemolytic anemia (MAHA), infections like malaria, enzymatic defects.
Pathogenesis
Destruction of RBCs occurs through various mechanisms:
- Complement-mediated lysis
- Phagocytosis by macrophages
- Mechanical fragmentation due to vascular stress
Hematologic Indices Used to Assess Hemolytic Anemia
Several hematologic indices help in diagnosing hemolytic anemia:
- Reticulocyte count: Increased due to compensatory erythropoiesis.
- Haptoglobin levels: Decreased due to hemoglobin binding.
- Lactate dehydrogenase (LDH): Elevated due to RBC destruction.
- Direct and indirect Coombs test: Helps in diagnosing autoimmune causes.
Peripheral Blood Characteristics
Typical peripheral blood smear findings include:
- Schistocytes (fragmented RBCs)
- Spherocytes
- Nucleated RBCs
- Polychromasia indicating active erythropoiesis
Conclusion
Acquired hemolytic anemia is a complex disorder with diverse etiologies. Understanding its pathogenesis and hematologic indices aids in accurate diagnosis and effective management.